Arterial stiffness and function in end-stage renal disease

Area of Science:

• Cardiovascular Medicine
• Nephrology
• Biomedical Engineering

Background:

• Cardiovascular disease is a leading cause of death in end-stage renal disease (ESRD) patients.
• Arterial stiffness significantly contributes to cardiovascular morbidity and mortality in ESRD.
• Arterial stiffness is a primary determinant of aortic input impedance, affecting left ventricular ejection.

Purpose of the Study:

• To explore the relationship between arterial stiffness and cardiovascular outcomes in ESRD.
• To investigate the mechanisms by which arterial stiffness impacts cardiovascular function.
• To evaluate the potential of interventions to improve arterial stiffness and patient survival.

Main Methods:

• Assessment of arterial stiffness using parameters like pulse wave velocity (PWV) and wave reflections.
• Evaluation of aortic input impedance components: total peripheral resistance (TPR), arterial distensibility, and wave reflections.
• Analysis of arterial wall composition, including collagen content, extracellular matrix, and calcification.

Main Results:

• Arterial stiffness is associated with elevated systolic and pulse pressures in ESRD.
• Increased PWV and wave reflections are independent predictors of survival in ESRD and the general population.
• Arterial stiffening negatively impacts left ventricular afterload and coronary perfusion.

Conclusions:

• Arterial stiffness is a critical factor in ESRD cardiovascular complications and mortality.
• Interventions targeting arterial stiffness, such as antihypertensive treatments (e.g., ACE inhibitors), show promise for improving outcomes.
• Reversibility of arterial stiffening, particularly with ACE inhibitors, offers a favorable survival benefit in hypertensive ESRD patients.